August 2026

Stroke prevention devices recalled | New Orleans surgeon makes history | New legislation could lead to better care ()
Catheters pulled from market | Updated HF guidelines | A key FDA approval | ACHD programs | New imaging systems | Heartflow data ()
Stroke prevention devices recalled | Texas cardiologist disciplined | Compensation on the rise | SCAI pushes back against policy ()
News Alert: Boston Scientific removes imaging catheters from market due to risk of injury ()
News Alert: FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes ()
Cardiologists call out unpopular policy | Cath lab kits recalled | PAD & AFib | Sex-based differences in mitral valve care ()
Surgery bests TAVR in young patients | The top US hospitals for cardiology & heart surgery | Preventing AFib ()
Impella controllers recalled | Top hospital makes big changes | FDA OKs wearable | Notable ASC moves | Predicting TAVR outcomes ()
ACC leader named STS CEO | The power of quality improvement | Tributes to a pioneer cardiologist | Is the US falling behind? ()
Cardiologist pay on the rise | Surgeon makes history with stroke treatment | New data on redo TAVR | AliveCor tech impresses ()
Recall Roundup: Key safety updates in the world of cardiology ()
Cardiologist disciplined after alleged mistake | What CCTA programs need to get ahead | FDA clears advanced AI software ()
The best US hospitals for heart care | Key details when treating older patients | How a cath lab transformed care | ASC progress ()
FDA confirms new recall | CKM syndrome in young adults | Digital twin tech impresses | $31M for new stroke robot | HF screening ()
Early signs of coronary plaque inflammation | ECG tech recalled | SAVR outperforms TAVR | CT & air pollution | A new lawsuit ()
FDA confirms recall for stroke prevention devices | Imaging trend leads to new challenges | The fight for safer cath labs ()
Getting the most out of AI | Cath lab transforms care | Hospital files lawsuit | TAVR & large aortic annuli | Doc's new role ()
SAVR bests TAVR in young patients | A close look at HCM trends | Murj announces patient monitoring platform | AHA backs new bill ()
New HFpEF recommendations | Changes in HCM care | FDA sees promise in gene therapy | Are flu shots good for the heart? ()
Opportunistic AI finds undetected aortic stenosis | Cutting CCTA energy costs | TMVR shows positive outcomes | How plaques begin ()
Banner embraces ASCs | ECG workstations recalled | FDA approves autoinjector for cholesterol drug | OCT for BTK interventions ()
Custom blood vessel grafts in minutes | FDA clears new peripheral thrombectomy tech | Blood clot removal device recalled ()
Things to consider when treating older patients | STS names new CEO | CT scans point to pollution risks | New tirzepatide data ()
Top 10 most popular cardiology video interviews this past month ()
Questioning Trump’s health | BP drug recalled | CT's burnout crisis | iRhythm to acquire rival for $288M | New drug falls short ()
Cardiac CT's future | New AI tech for inflammation | Is the US falling behind? | ChatGPT’s medical advice leads to lawsuit ()
HCM care keeps evolving | FDA clears next-gen thrombectomy device | New IVL research | Medtronic leader named CEO of startup ()
The first mitral valve repair of its kind | Real-world TriClip data | New PARTNER 3 update | Topaz vs. Evoque ()
BP drug recalled | Digital twin tech shows promise | A new TAVR technique | Cardiologist questions Trump’s health ()
Medicare cuts on the way | Does TAVR for asymptomatic patients save money? | Medtronic leads $37M investment ()
Cardiac CT's future | Incidental findings & TAVR | Abbott & Google join forces | Abdominal fat & CVD | FDA clears Bracco tech ()
Cardiologists want safer cath labs | 2 recalls to keep an eye on | New PCI data | AI tech impresses ()
Robotics in electrophysiology | Impella accessories recalled | iRhythm to acquire rival for $288M | Tributes to a pioneer ()
Advocates celebrate ASC momentum | Flu shots & the heart | Blood thinner recalled | AFib after surgery | FDA clears AI software ()
Key takeaways from an expert panel on TAVR | Burnout just getting worse | AHA pushes back against FDA | Medtronic's new approval ()
Blood thinner recalled | The best heart hospitals in the US | Fighting for workplace safety | ACC shares a new resource ()
FDA authorizes new-look AI tech for inflammation | SCCT's new president | Contrast agent recalled | CCTA & complex PCI ()
New vaccine recommendations | Shared cardiac PET programs | Heart drug falls short in trial | Robotics company raises $6M ()
The fight for safer cath labs continues | California procedure seen as a major milestone | When diabetic patients undergo PCI ()
TAVR Highlights: Medical societies take a stand | Comparing anesthesia strategies | AI flags untreated valve disease | Much more ()
Automated CT scans? There are some concerns | Contrast agent recalled | ASE shares new safety guidance | Interventional MR labs ()
How much coffee is too much? | Many more adults now eligible for statin therapy | Cardiologist's new role | Cannabis & CVD ()
The best heart hospitals in the US | Blood thinner recalled | The economics of TAVR for patients with asymptomatic AS ()
Looking Back: Compensation keeps rising | Major recalls | FDA approves new cholesterol pill | ACC shares DOAC recommendations ()
Heart failure patients can treat edema at home | ACC Medicare fee calculator | Nonobstructive HCM drug gets FDA priority ()
Week in Review: FDA clears inflammation imaging | Cardiologist accused of abusing patients | Impact of Get With Guidelines HF ()